Click points to explore news by date. News sentiment ranges from -10 (very negative) to +10 (very positive) where 0 is neutral.
View Most Recent PFE News
Assets that tend to move strongly with PFE
Assets that tend to move strongly against PFE
STAT+: Pharmalittle: Medicare is poised to negotiate drug prices; Pfizer to pay $5.4 billion for Global Blood Therapeutics
Good morning, everyone, and welcome to another working week. We hope the weekend respite was somehow relaxing and refreshing, despite the ongoing heat. Now, though, that oh-so-predictable routine of online meetings and deadlines has returned. You knew this would happen, yes? After all, the world — such as it is — keeps spinning. So why not give it a nudge in a better direction with a cup or three of stimulation? Our choice today is, again, vanilla macadamia nut. Feel free to join us. Or grab a bottle of water if you prefer. Meanwhile, here is the latest menu of tidbits to help you get started.
— (STAT) (August 8) (Pocket)
WASHINGTON, Aug 12 (Reuters) - Big Pharma spent more than any other industry to lobby Congress and federal agencies this year, a Reuters analysis shows, but still suffered a major defeat after failing to stop a bill that allows the government to negotiate prices on select drugs.
— (Reuters) (August 17) (Pocket)
Retiree Donna Weiner shows some of the daily prescription medications that she needs and pays over $6,000 a year through a Medicare prescription drug plan at her home, Tuesday, Oct. 5, 2021, in Longwood, Fla. Weiner supports giving Medicare authority to negotiate drug prices. Negotiating Medicare drug prices is the linchpin of President Joe Biden’s ambitious health care agenda. Not only would consumers see lower costs, but savings would be plowed into other priorities such as dental coverage for retirees and lower premiums for people with plans under the Obama-era health law. (AP Photo/Phelan M. Ebenhack)
— (Miami Herald) (August 8) (Pocket)
Medicare is on track to negotiate drug prices, thanks to the Inflation Reduction Act --- what it means for you - MarketWatch
There are several proposed changes for Medicare and its beneficiaries under the Senate budget reconciliation bill from Senate Majority Leader Chuck Schumer, D-NY, and Sen. Joe Manchin, D-WV, which was approved over the weekend. The House is expected to pass the legislation this week, according to media reports.
— (Market Watch) (August 8) (Pocket)
Democrats have been campaigning for 30 years on promises they'd let Medicare directly negotiate the cost of prescription drugs — and after all that time, they might finally be about to achieve it.Why it matters: The Senate's reconciliation bill would only open up negotiations for a small number of drugs, but even that is a threshold Democrats have never before been able to cross. And it opens the door to more aggressive policies in the future.Flashback: Then-president Bill Clinton proposed direct negotiations between drug companies and the federal government in 1993. Clinton, Al Gore, Barack Obama, Hillary Clinton, Joe Biden — and even Donald Trump — each embraced the idea while in office or as candidates, only ...
— (Axios) (August 1) (Pocket)
@VP: Now that we've passed the Inflation Reduction Act, Medicare will be able to negotiate prescription drugs and cap insulin co-pays at $35 a month.
@WhiteHouse: By capping the amount of money seniors pay on prescription drugs at $2,000 a year and giving Medicare the power to negotiate prescription drug prices, the Inflation Reduction Act delivers on President Biden’s promise to make prescription drugs cheaper for millions of Americans.
@RepValDemings: The Inflation Reduction Act allows Medicare to negotiate lower drug prices and save Floridians $ on their prescriptions.
KIAWAH ISLAND, S.C. (AP) — First lady Jill Biden tested positive for COVID-19 and was experiencing “mild symptoms,” the White House announced Tuesday. President Joe Biden continues to test negative after recently recovering from the virus but will wear a mask indoors for 10 days as a precaution.
— (PBS) (August 16) (Pocket)
Pfizer Inc Chief Executive Officer Albert Bourla said on Monday he had tested positive for COVID-19 and was experiencing very mild symptoms.Bourla, 60, said he had started a course of the company's oral COVID-19 antiviral treatment, Paxlovid, and was isolating and following all public health precautions."I am confident that I will have a speedy recovery," Bourla said in a statement."I am confident that I will have a speedy recovery."Pfizer CEO Albert Bourla
— (Jerusalem Post) (August 15) (Pocket)
2022 © Helium Trades
* Disclaimer: Nothing on this website constitutes investment advice, performance data or any recommendation that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. Helium Trades is not responsible in any way for the accuracy of any model predictions or price data. Any mention of a particular security and related prediction data is not a recommendation to buy or sell that security. Investments in securities involve the risk of loss. Past performance is no guarantee of future results. Helium Trades is not responsible for any of your investment decisions, you should consult a financial expert before engaging in any transaction.